Too Much Hype in the Mobile Health App World? | Barbara Ficarra in the Huffington Post
I sent the following announcement to 11,893 Digital Health group on LinkedIn members on July 23, 2012:
Dear Digital Health group members,
While I always like to share with you relevant media coverage of the group and my efforts related to it (please do follow me on Twitter @Paul_Sonnier), a recent article by Barbara Ficarra, a journalist and founder of http://healthin30.com, is particularly insightful; in this case regarding the state of health apps. My sincere thanks to Barbara for mentioning the Digital Health group.
“Too Much Hype in the Mobile Health App World?” by Barbara Ficarra
Further indication of why this is such a great piece is the group members Barbara interviewed for it: Dr. Joe Kvedar and Dr. David Lee Scher. Dr. Kvedar, as most of you probably already know, is the Director of the Center for Connected Health and a fellow mentor of mine at Blueprint Health, the TechStars-affiliated startup accelerator program based in NYC that helps early stage healthcare companies get started. Dr. Scher is a consultant and senior medical advisor to Happtique, which is working to certify medical, health, and fitness apps.
As Barbara astutely points out, “It doesn’t seem as if there is too much hype – just little guidance. The push to move the mHealth app world forward may be in the power of consumers to clamor for health and wellness apps that are safe, reliable and trustworthy.”
I wholeheartedly agree that consumers can catalyze the digital health revolution. By enabling them to choose the right technological aids, they will be further empowered to improve their own health and make better healthcare-related decisions. This creates a powerful positive feedback loop between consumers and healthcare systems, which are also undergoing a major transformation due to the digital revolution.
Lastly, on a separate note, I wanted to update you on the results of the recent group poll, which has received 360 total votes so far.
#1 – Disease management – 178 (49%)
#2 – Disease prevention – 111 (30%)
#3 – Disease diagnosis – 41 (11%)
#4 – Disease prediction (especially genomics) – 25 (6%)
#5 – Reduced radiation exposure (imaging) – 5 (1%)
Disease management obviously came out on top for the immediate benefits we’re seeing. There was also some great ensuing discussion. For a summary of my thoughts on the poll, please see my post on the Popper and Company blog:
Thanks again and, if you derive value from the group, please tell your friends and colleagues about it. They can join here.